UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

AB1182-HPR Development and Implementation of A Multidisciplinary Management Tool of Biological Therapies in Arthropathies

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.1228-1228

2014

Volltextzugriff (PDF)

P84.16 Treatment Options for Patients with Brain Metastases in Oncogene-Driven Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S663-S665

2021

Volltextzugriff (PDF)

Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV/hepatitis C virus coinfected individuals

AIDS (London), 2019-03, Vol.33 (4), p.685-689

2019

Volltextzugriff (PDF)

Metastasis of gastrico origin in the breast

European journal of surgical oncology, 2019-02, Vol.45 (2), p.e109-e109

2019

Volltextzugriff (PDF)

PGI16 COST-EFFECTIVENESS OF TOFACITINIB FOR THE TREATMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS AFTER BIOLOGIC FAILURE OR INTOLERANCE IN SPAIN

Value in health, 2019-11, Vol.22, p.S619-S619

2019

Volltextzugriff (PDF)

PGI17 COST-EFFECTIVENESS OF TOFACTINIB FOR THE TREATMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS AFTER CONVENTIONAL THERAPY IN SPAIN

Value in health, 2019-11, Vol.22, p.S619-S619

2019

Volltextzugriff (PDF)

749P Cardiotoxicity in patients treated with PARP-inhibitors

Annals of oncology, 2021-09, Vol.32, p.S743-S743

2021

Volltextzugriff (PDF)

CP-149 Redesign of the management model and pharmaceutical care of patients with hepatitis C virus infection

European journal of hospital pharmacy. Science and practice, 2016-03, Vol.23 (Suppl 1), p.A66-A66

2016

Volltextzugriff (PDF)

P533 Adalimumab 80mg every other week in inflammatory bowel disease: Treatment intensification outcomes in real life clinical practice

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S507-S509

2021

Volltextzugriff (PDF)

DI-064 Botulinum toxin type A: experience with 51 patients of a neurology department

European journal of hospital pharmacy. Science and practice, 2014-03, Vol.21 (Suppl 1), p.A96-A96

2014

Volltextzugriff (PDF)

P545 Deep remission assessed by endoscopy, magnetic resonance or intestinal ultrasound, in refractory Crohn’s disease patients in clinical remission with ustekinumab: a real-life single-centre experience

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S464-S465

2020

Volltextzugriff (PDF)

Medication reconciliation at admission and discharge. A consolidated experience

Revista de calidad asistencial, 2016-06, Vol.31 Suppl 1, p.45-54

2016

Volltextzugriff (PDF)

2SPD-003 Monitoring the use of linezolid in a third-level hospital

European journal of hospital pharmacy. Science and practice, 2019-03, Vol.26 (Suppl 1), p.A20-A20

2019

Volltextzugriff (PDF)

Conciliación de la medicación al ingreso y alta hospitalaria. Una experiencia consolidada

Revista de calidad asistencial, 2016-06, Vol.31, p.45-54

2016

Volltextzugriff (PDF)

Immunohystochemical and prognosis features of adenocarcinoid tumor of the ampulla of Vater

Revista española de enfermedades digestivas, 2006-12, Vol.98 (12), p.966

2006

Volltextzugriff (PDF)

Perfil molecular del cáncer colorrectal sin afectación ganglionar de mal pronóstico mediante la determinación inmunohistoquímica de p53, ki67, VEGF y metaloproteinasa 9.: ¿Es útil como modelo pronóstico de recidiva? Molecular pattern of poor prognostic colorectal cancer without nodular involvement by immunohistochemical determination of p53, ki67, VEGF and metaloproteinase 9.: It is useful as prognostic marker of recurrency?

Revista española de enfermedades digestivas, 2007-07, Vol.99 (7), p.424-425

2007

Volltextzugriff (PDF)

Perfil molecular del cáncer colorrectal sin afectación ganglionar de mal pronóstico mediante la determinación inmunohistoquímica de p53, ki67, VEGF y metaloproteinasa 9.: ¿Es útil como modelo pronóstico de recidiva?

Revista española de enfermedades digestivas, 2007-07, Vol.99 (7), p.424-425

2007

Volltextzugriff (PDF)

PS-089 Medicines reconciliation and medication review in elderly polymedicated patients at hospital admission

European journal of hospital pharmacy. Science and practice, 2014-03, Vol.21 (Suppl 1), p.A179-A179

2014

Volltextzugriff (PDF)

P378 Mucosal healing is achieved in most of the inflammatory bowel disease patients in clinical remission with vedolizumab: a real-life single-centre experience

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S355-S355

2020

Volltextzugriff (PDF)

CP-163 Analysis of the side effects and the treatment discontinuation of dimethyl fumarate in a tertiary hospital

European journal of hospital pharmacy. Science and practice, 2016-03, Vol.23 (Suppl 1), p.A72-A72

2016

Volltextzugriff (PDF)

Molecular profile of node-negative colorectal cancer of poor prognosis using immunohistochemical determination of p53, ki67, VEGF, and metalloproteinase-9

Revista española de enfermedades digestivas, 2007-07, Vol.99 (7), p.424-425

2007

Volltextzugriff (PDF)

Aspectos inmunohistoquímicos y pronósticos del tumor adenocarcinoide de la ampolla de Vater Immunohystochemical and prognosis features of adenocarcinoid tumor of the ampulla of Vater

Revista española de enfermedades digestivas, 2006-12, Vol.98 (12), p.966-968

2006

Volltextzugriff (PDF)

Aspectos inmunohistoquímicos y pronósticos del tumor adenocarcinoide de la ampolla de Vater

Revista española de enfermedades digestivas, 2006-12, Vol.98 (12), p.966-968

2006

Volltextzugriff (PDF)

Aspectos inmunohistoquímicos y pronósticos del tumor adenocarcinoide de la ampolla de Vater

Revista española de enfermedades digestivas, 2006-12, Vol.98 (12)

2006

Volltextzugriff (PDF)

De Novo Mutations in FOXJ1 Result in a Motile Ciliopathy with Hydrocephalus and Randomization of Left/Right Body Asymmetry

American journal of human genetics, 2019-11, Vol.105 (5), p.1030-1039

2019

Volltextzugriff (PDF)

1 – 25 von 101

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

AB1182-HPR Development and Implementation of A Multidisciplinary Management Tool of Biological Therapies in Arthropathies

P84.16 Treatment Options for Patients with Brain Metastases in Oncogene-Driven Non-Small Cell Lung Cancer

Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV/hepatitis C virus coinfected individuals

Metastasis of gastrico origin in the breast

PGI16 COST-EFFECTIVENESS OF TOFACITINIB FOR THE TREATMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS AFTER BIOLOGIC FAILURE OR INTOLERANCE IN SPAIN

PGI17 COST-EFFECTIVENESS OF TOFACTINIB FOR THE TREATMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS AFTER CONVENTIONAL THERAPY IN SPAIN

749P Cardiotoxicity in patients treated with PARP-inhibitors

CP-149 Redesign of the management model and pharmaceutical care of patients with hepatitis C virus infection

P533 Adalimumab 80mg every other week in inflammatory bowel disease: Treatment intensification outcomes in real life clinical practice

DI-064 Botulinum toxin type A: experience with 51 patients of a neurology department

P545 Deep remission assessed by endoscopy, magnetic resonance or intestinal ultrasound, in refractory Crohn’s disease patients in clinical remission with ustekinumab: a real-life single-centre experience

Medication reconciliation at admission and discharge. A consolidated experience

2SPD-003 Monitoring the use of linezolid in a third-level hospital

Conciliación de la medicación al ingreso y alta hospitalaria. Una experiencia consolidada

Immunohystochemical and prognosis features of adenocarcinoid tumor of the ampulla of Vater

Perfil molecular del cáncer colorrectal sin afectación ganglionar de mal pronóstico mediante la determinación inmunohistoquímica de p53, ki67, VEGF y metaloproteinasa 9.: ¿Es útil como modelo pronóstico de recidiva?

PS-089 Medicines reconciliation and medication review in elderly polymedicated patients at hospital admission

P378 Mucosal healing is achieved in most of the inflammatory bowel disease patients in clinical remission with vedolizumab: a real-life single-centre experience

CP-163 Analysis of the side effects and the treatment discontinuation of dimethyl fumarate in a tertiary hospital

Molecular profile of node-negative colorectal cancer of poor prognosis using immunohistochemical determination of p53, ki67, VEGF, and metalloproteinase-9

Aspectos inmunohistoquímicos y pronósticos del tumor adenocarcinoide de la ampolla de Vater Immunohystochemical and prognosis features of adenocarcinoid tumor of the ampulla of Vater

Aspectos inmunohistoquímicos y pronósticos del tumor adenocarcinoide de la ampolla de Vater

Aspectos inmunohistoquímicos y pronósticos del tumor adenocarcinoide de la ampolla de Vater

De Novo Mutations in FOXJ1 Result in a Motile Ciliopathy with Hydrocephalus and Randomization of Left/Right Body Asymmetry

Suchergebnisse filtern